How to Get a GLP-1 Prescription: What Doctors Look For & How to Prepare

Getting a GLP-1 prescription is easier than most people think.

Key Takeaways

• Two routes: In-person physician or telehealth — telehealth can get you a prescription the same week; in-person builds a longer provider relationship.
• What qualifies you: BMI ≥30, or BMI ≥27 with a weight-related condition — T2D, hypertension, sleep apnea, high cholesterol, or cardiovascular disease.
• What to bring: Recent labs (A1c, lipid panel, metabolic panel), comorbidity documentation, and history of prior weight loss efforts.
• How to ask: Frame it as a metabolic health intervention, mention qualifying conditions specifically, and ask directly: "Am I a candidate for a GLP-1 receptor agonist?"
• If your doctor says no: Ask for the specific reason, seek a second opinion, or use telehealth — it's a legitimate medical route, not a workaround.
• Timeline: Telehealth can put medication in your hands in 3–5 business days; in-person typically takes 1–3 weeks including lab turnaround.

Most people assume getting a GLP-1 prescription requires convincing a skeptical doctor, fighting insurance for months, and waiting indefinitely. Some of that is true for some people. But the path is far more navigable than it was even two years ago — because obesity is now routinely recognized as a medical condition, not a character flaw, and the clinical criteria for these medications are clear enough that a prepared patient can walk into an appointment knowing exactly what to say and what to bring. Here's how to do that.

The two main routes to a prescription

Your first decision is where to go.

The in-person route means seeing your primary care physician or an obesity medicine specialist. The advantage is a longitudinal relationship — your doctor knows your full health history, manages all your medications, and can integrate GLP-1 therapy into your overall care. If you already have a primary care doctor you see regularly, this is often the most medically coherent approach. The limitation is timing: getting an appointment, running labs, and returning for a prescription can take two to four weeks or longer in many practices.

Telehealth platforms that specialize in obesity and metabolic health have changed the timeline substantially. The standard process through a telehealth provider — a brief intake form, an asynchronous or synchronous consultation with a licensed physician or nurse practitioner, and an e-prescription sent to a pharmacy — can be completed in a matter of days. Many platforms report same-week prescriptions for straightforward cases. If you need medication quickly and don't have an established relationship with a physician who manages weight, telehealth is not a corner-cutting shortcut. It is a legitimate, regulated medical pathway.

What actually qualifies you

FDA eligibility criteria define exactly who can receive these prescriptions.

A BMI of 30 or higher qualifies you without any additional conditions — that is the threshold for obesity by clinical classification. A BMI of 27 or higher qualifies you if you also have at least one of the following weight-related conditions: type 2 diabetes, hypertension (high blood pressure), obstructive sleep apnea, dyslipidemia (elevated LDL cholesterol, low HDL, or elevated triglycerides), or established cardiovascular disease.

These are not vague aspirational criteria. They are the specific indications in the FDA approval language for Wegovy, Zepbound, and Saxenda. A physician prescribing to a patient who meets these criteria is prescribing within approved indications — there is nothing gray about it from a medical-legal standpoint.

A BMI of 27 is lower than most people assume. Someone who is 5'8" and weighs 178 pounds sits right at BMI 27. If that person also has high blood pressure — which co-occurs with excess weight at high rates — they qualify for a GLP-1 prescription under FDA criteria today.

One common misconception: you do not need to have failed every other weight loss approach before a doctor can prescribe a GLP-1 medication. The FDA does not require "step therapy" as a condition of eligibility. Your insurance plan's prior authorization process may require documentation of prior attempts — but that is an insurance requirement, not an FDA or physician requirement. The two are different and shouldn't be confused.

What to bring to your appointment

Preparation shortens the process significantly.

The most useful thing you can bring is recent lab work. An HbA1c (three-month average blood sugar), a lipid panel (LDL, HDL, triglycerides), and a basic metabolic panel (kidney function, liver enzymes, electrolytes, blood glucose) give your provider the information they need to prescribe safely and set a baseline for monitoring. If you've had these done in the last six months, bring the results. If you haven't, your provider will order them — but having them in hand at the first visit removes one appointment cycle from the process.

Documentation of any qualifying comorbidities is equally valuable. If you have hypertension, bring your blood pressure readings or a letter from your cardiologist. If you have type 2 diabetes or prediabetes, bring your most recent A1c and any relevant records. If you have a sleep apnea diagnosis, bring the sleep study documentation.

For insurance purposes — particularly if prior authorization is coming — a brief written history of your weight loss efforts is useful. This does not need to be formal or elaborate: a few sentences noting what approaches you've tried (specific diets, exercise programs, medications), for how long, and what the results were. Your physician needs this to build the PA narrative if required.

How to talk to your doctor

Framing matters more than it should.

Physicians who have been in practice for 20+ years were trained in an era when obesity was treated primarily as a behavioral problem. Some of that thinking persists. If you walk into an appointment asking for "a weight loss drug," you may encounter more resistance than if you walk in framing the conversation around metabolic health, documented conditions, and a specific therapeutic question.

Here is language that works: "I've been reading about GLP-1 receptor agonists as a treatment for metabolic dysfunction and weight management. My BMI is [X], and I also have [hypertension / prediabetes / sleep apnea]. Am I a candidate for a GLP-1 receptor agonist like semaglutide or tirzepatide?"

This phrasing accomplishes several things at once. It names the drug class correctly, signaling that you've done real research. It ties the request to your specific documented conditions. It asks a clinical question rather than making a demand. And it opens a conversation your doctor can engage with professionally rather than putting them on the defensive.

Which GLP-1 drugs are available for weight management

The options in 2026 are broader than most people realize.

Injectable options approved specifically for weight management include Wegovy (semaglutide 2.4mg, weekly injection), Zepbound (tirzepatide, weekly injection), and Saxenda (liraglutide 3mg, daily injection). Wegovy and Zepbound are the two most commonly prescribed for obesity — they produce the most substantial weight loss in trials and have the longest safety records in the obesity indication.

Oral options approved for weight management include the Wegovy pill (oral semaglutide 50mg, daily) and Foundayo/orforglipron (a non-peptide oral GLP-1 agonist, also daily). These are particularly relevant for patients who are averse to injections or need a more convenient daily pill format.

Several additional drugs — Ozempic, Mounjaro, Rybelsus, Victoza, Trulicity — are approved for type 2 diabetes but are frequently prescribed off-label for weight management in patients who don't have diabetes. This is a common and accepted practice; your physician may prefer an off-label diabetes drug in some situations, particularly for patients who also have blood sugar concerns.

What to do if your doctor says no

A refusal is not the end of the road.

First, ask specifically why. "No" can mean several different things: "I don't think you meet clinical criteria" (ask them to explain which criteria you don't meet), "I'm not comfortable prescribing these medications" (a second opinion is entirely appropriate), or "your insurance won't cover it" (an insurance concern, not a medical refusal). Each of these has a different response.

If your doctor is genuinely unfamiliar with obesity medicine or has philosophical objections to GLP-1 therapy, a second opinion from a physician who specializes in this area is a reasonable and professional step — not an act of defiance. Obesity medicine specialists, endocrinologists, and many internists are well-versed in these medications and see this type of case routinely.

Telehealth is also a fully legitimate alternative path. Licensed physicians on telehealth platforms practice under the same medical standards as in-person providers. If you meet clinical criteria, a telehealth prescriber can evaluate and prescribe just as a clinic-based physician can. This is not a regulatory workaround; it is how regulated telemedicine works.

Insurance prior authorization: what actually happens

Prior authorization is required for most GLP-1 prescriptions on commercial insurance.

After your physician writes the prescription, the PA process begins. Your physician submits a request to your insurer that includes: your BMI, documentation of qualifying comorbidities, relevant lab values, and a clinical narrative explaining medical necessity. The insurer reviews it — typically within 3–14 days for a standard review — and either approves, denies, or requests additional information.

Initial denial rates run roughly 20–40% depending on the plan and the drug. An initial denial does not mean the case is closed. Your physician can request a peer-to-peer review — a phone call between your doctor and the insurance company's medical reviewer — which significantly increases approval rates. Approval on peer-to-peer review runs 60–70% in many plan types.

If peer-to-peer review also fails, you can request an external independent review. At this stage, most clinically appropriate cases get approved. The process is slow — and frustrating — but the path through denial is navigable.

One practical tip: ask your prescriber whether their office has a dedicated prior authorization staff member or service. Practices that handle GLP-1 PAs regularly have learned which documentation each major insurer requires to avoid back-and-forth delays. A PA submitted correctly the first time is approved faster and denied less often than an incomplete initial submission.

What happens right after the prescription is written

The prescription is just the beginning of a process.

Your physician will specify the starting dose and the titration schedule. For semaglutide, the standard starting dose is 0.25mg weekly for the first four weeks — a tolerance-building dose that doesn't produce much therapeutic effect on its own. For tirzepatide, the starting dose is 2.5mg weekly. Your prescription will typically include enough dose steps to cover the first several months of treatment.

Follow-up appointments are scheduled at four weeks and twelve weeks in most protocols — earlier if you're having significant side effects. Labs are rechecked at three months. Most prescribers want to hear from you if you experience persistent nausea, vomiting, or any unusual symptoms at any dose step.

The medication itself — particularly at telehealth platforms — typically arrives within 3–5 business days after the prescription is sent to the pharmacy. Brand-name drugs at retail pharmacies depend on stock at your specific location.

Frequently Asked Questions

Can I get a GLP-1 prescription without insurance?
Yes. Physicians can prescribe GLP-1 medications to any patient who meets clinical criteria regardless of insurance status. Without insurance, the cost of the drug is the main challenge — see savings programs, Patient Assistance Programs, and telehealth bundled pricing options. Your prescriber can write the prescription; payment is a separate question from eligibility.

Do I need to see a specialist, or can my regular doctor prescribe this?
A primary care physician, internal medicine doctor, or family medicine physician can all prescribe GLP-1 medications. You do not need a referral to an obesity medicine specialist, though specialists have deeper experience with complex cases. Most straightforward prescriptions happen in primary care.

Is telehealth a legitimate way to get a GLP-1 prescription?
Yes. Telehealth prescribers are licensed physicians or nurse practitioners practicing under the same medical regulations as in-person providers. They perform clinical evaluations, review records, order labs, and prescribe based on the same FDA criteria. There is no clinical or ethical reason to treat a telehealth GLP-1 prescription as inferior to one written in a clinic.

What if my BMI is under 27?
The FDA-approved indications for GLP-1 weight management drugs currently require a BMI of 27 or higher (with a comorbidity) or 30 or higher. Below BMI 27 without a qualifying condition falls outside the approved indication. Off-label prescribing is at physician discretion, but it is uncommon for weight management in patients with a BMI under 27, and insurance coverage is unlikely. Discuss with your provider what options may be appropriate for your specific situation.

How long does the full prescription process take?
Telehealth: 3–7 business days from initial consultation to medication in hand, assuming no PA complications. In-person with an established doctor: 1–2 weeks if labs are already on file, 2–4 weeks if labs need to be ordered. If insurance prior authorization is required: add 1–4 weeks for the PA process, longer if an appeal is needed.

This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before starting any medication.